METASTATIC ADENOCARCINOMA OF THE PANCREAS
Clinical trials for METASTATIC ADENOCARCINOMA OF THE PANCREAS explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ADENOCARCINOMA OF THE PANCREAS trials appear
Sign up with your email to follow new studies for METASTATIC ADENOCARCINOMA OF THE PANCREAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for pancreatic cancer: drug combo shows promise in early trial
Disease control CompletedThis study tested a new combination of four drugs (irinotecan liposome, oxaliplatin, 5-FU, and leucovorin) in 41 Japanese adults with advanced pancreatic cancer that had not been treated before. The goal was to see if the treatment could shrink tumors and to check its safety. Par…
Matched conditions: METASTATIC ADENOCARCINOMA OF THE PANCREAS
Phase: PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated May 26, 2026 10:41 UTC
-
New chemo combo tested against standard for deadly pancreatic cancer
Disease control CompletedThis study tested a new combination of chemotherapy drugs (irinotecan liposome, oxaliplatin, 5-FU, and leucovorin) against the current standard treatment (nab-paclitaxel plus gemcitabine) in 770 people with metastatic pancreatic cancer who had not yet received chemotherapy. The g…
Matched conditions: METASTATIC ADENOCARCINOMA OF THE PANCREAS
Phase: PHASE3 • Sponsor: Ipsen • Aim: Disease control
Last updated May 20, 2026 11:57 UTC